Accession Therapeutics

About:

Accession Therapeutics is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumor diversity.

Website: https://www.accessiontherapeutics.com

Top Investors: Primavera Capital Group, iGlobe Partners, Birk Venture

Description:

Accession Therapeutics is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumor diversity. It is the first company to have engineered a viral point of entry to cancer cells while bypassing healthy cells - so it’s ‘gloves off’ in the fight against cancer." It was founded in 2020 and is located in Oxford, Oxfordshire, United Kingdom.